Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
NCT05080270
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis
Interventions
BIOLOGICAL:
Tolerogenic Fibroblasts
Sponsor
FibroBiologics